Post Acne ScarsPhase 4NCT06943118
Comparison of Efficacy of 35% Glycolic Acid vs 20% Salicylic Acid Peel in the Treatment of Post Acne Scars
A Phase 4 study testing Chemical Peels in people with Post Acne Scars, run by Hayatabad Medical Complex at 1 site in Pakistan.
Trial summary
The goal of this clinical trial is to compare the effectiveness of two drugs in patients that presents with scars on face after acnes. The effectiveness will be measured by a goodman and baron scale. Read more about this study
- Who is it for?
- Ages 18 to 45 years
- Conditions the study is for
- Post Acne Scars
- What is being tested?
- Chemical Peels
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 sitePakistan
- Study dates
- Apr 2025to Oct 2025
- Phase
- Phase 4
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Patients aged 18-45 years with mild to moderate atrophic post acne scars
- Fitzpatrick skin type 2-4
- No active acne or ongoing systemic acne treatment
Who cannot join
- Pregnancy and breast feeding
- History of keloid or hypertrophic scars
- Use of retinoids or chemical peel in last 3 months
- Active skin infections
- History of hyperpigmentation after any procedure
- Hypersensitivity to aspirin
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Naheed Asghar, MBBS,FCPS contact
About this study
The goal of this clinical trial is to compare the effectiveness of two drugs in patients that presents with scars on face after acnes. The effectiveness will be measured by a goodman and baron scale. One group of patients will receive 35% glycolic acid while other group of patients will receive 20% salicylic acid and both groups will be followed by 12 weeks.
- Conditions
- Post Acne Scars
- Being tested
- Chemical Peels
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Chemical PeelsProcedure or surgery
Chemical peel is a dermatological procedure in which chemical solution is applied to the skin to remove the top layer
| Study group | Role | What they receive |
|---|---|---|
| 35% glycolic acid peel | Experimental | Not described Receives: Procedure: Chemical Peels |
| 20% salicylic acid | Experimental | Not described Receives: Procedure: Chemical Peels |
What is being measured
The primary outcome is the main question the study is designed to answer.
improvement in acne scars as per Goodman and baron scale
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2025
- Study startApr 2025 (estimated)
- Primary completionOct 2025 (estimated)
- Study completionOct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post Acne ScarsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hayatabad Medical Complex
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Naheed asghar, Hayatabad Medical Complex
- Investigators
- khizar hayat, MBBS, Study chair, Hayatabad Medical Complex Peshawar, KPK pakistan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06943118
- Sponsor's protocol ID
- Hayatabad Medical Complex
- Status last verified
- Mar 2025
- First submitted
- 17 Apr 2025
- Last updated
- 24 Apr 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Efficacy of 35% Glycolic Acid vs 20% Salicylic Acid Peel in the Treatment of Post Acne Scars
- ClinicalTrials.gov ID
- NCT06943118
- Acronym / sponsor ID
- Hayatabad Medical Complex
- Conditions
- Post Acne Scars
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Hayatabad Medical ComplexOther government
- Study start
- Apr 2025 (estimated)
- Primary completion
- Oct 2025 (estimated)
- Study completion
- Oct 2025 (estimated)
- First posted
- 24 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to compare the effectiveness of two drugs in patients that presents with scars on face after acnes. The effectiveness will be measured by a goodman and baron scale. One group of patients will receive 35% glycolic acid while other group of patients will receive 20% salicylic acid and both groups will be followed by 12 weeks.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 35% glycolic acid peel | Experimental | Procedure: Chemical Peels |
| 20% salicylic acid | Experimental | Procedure: Chemical Peels |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Patients aged 18-45 years with mild to moderate atrophic post acne scars
- Fitzpatrick skin type 2-4
- No active acne or ongoing systemic acne treatment
Key exclusion criteria (6 listed)
- Pregnancy and breast feeding
- History of keloid or hypertrophic scars
- Use of retinoids or chemical peel in last 3 months
- Active skin infections
- History of hyperpigmentation after any procedure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Chemical PeelsChemical peel is a dermatological procedure in which chemical solution is applied to the skin to remove the top layer | Procedure or surgery | 20% salicylic acid, 35% glycolic acid peel |
Primary outcome
improvement in acne scars as per Goodman and baron scale
Time frame: 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Post Acne Scars
Enrolling by invitationPhase 2/3
A Split-Face Comparative Study of Mono Threads Versus Combination With Plasma Gel for the Treatment of Post-Acne Scars
Acne
Not yet recruiting
Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars
Acne Scars - Atrophic
Recruiting
PRP Plus Fractional CO₂ Laser for Acne Scars
Post-Acne Atrophic Scars, Carbon Dioxide Lasers
Not yet recruiting
Subcision With CO₂ Laser or PRP vs Subcision Alone in Atrophic Acne Scars
Atrophic Acne Scar
RecruitingObservational study
PMCF Investigation of Medical Device ChitoCare® Medical
Dermatitis, Acne
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Naheed Asghar, MBBS,FCPS contact
khizar hayat, MBBS study chair
Hayatabad Medical Complex Peshawar, KPK pakistan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Chemical Peels in people with Post Acne Scars, run by Hayatabad Medical Complex at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Khizar Hayat, MBBS (+923159446988, ayubian944@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
improvement in acne scars as per Goodman and baron scale (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2025.